In Brazil, the annual incidence of myocardial infarction is estimated at approximately 300,000 to 400,000 cases. Despite advancements in treatment, myocardial infarction remains the leading cause of death in Brazil and globally, with a lethality rate of around 9%. According to the BRACE registry, acute coronary syndrome (ACS) accounts for 45% of hospitalizations in Brazil, with two-thirds attributed to acute myocardial infarction (AMI), including both ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). Notably, 40% to 60% […]